Cognition Therapeutics Ownership | Who Owns Cognition Therapeutics?

Overview RevenueFinancials Chart Transcripts

Cognition Therapeutics Ownership Summary

Cognition Therapeutics is owned by 10.38% institutional investors, 0.54% insiders, and 89.08% retail investors. Vanguard group is the largest institutional shareholder, holding 3.40% of CGTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.52% of its assets in Cognition Therapeutics shares.

CGTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Cognition Therapeutics	10.38%	0.54%	89.08%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	1.15M	3.40%	$1.90M
Alyeska investment group	500.00K	1.48%	$830.00K
Geode capital management	244.77K	0.73%	$406.39K
American financial group	205.00K	0.61%	$340.00K
Cm management	200.00K	0.59%	$332.00K
Kestra advisory services	188.43K	0.56%	$312.80K
Sigma planning	172.14K	0.51%	$285.75K
Blackrock	152.58K	0.45%	$253.28K
Mercer global advisors inc /adv	95.95K	0.28%	$159.28K
Commonwealth equity services	90.67K	0.27%	$151.00K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Cm management	200.00K	0.30%	$332.00K
American financial group	205.00K	0.15%	$340.00K
Castle wealth management	43.38K	0.03%	$72.01K
Fca corp /tx	51.47K	0.03%	$85.44K
Texas capital bank wealth management services	55.40K	0.01%	$91.96K
Sigma planning	172.14K	0.01%	$285.75K
Bangor savings bank	34.02K	0.01%	$56.47K
Alyeska investment group	500.00K	0.00%	$830.00K
Bridgeway capital management	76.70K	0.00%	$127.32K
Smith anglin financial	12.00K	0.00%	$19.92K

Top Buyers

Holder	Shares	% Assets	Change
Vanguard group	1.15M	-	225.87K
Blackrock	152.58K	-	96.76K
Geode capital management	244.77K	-	59.57K
Envestnet asset management	30.00K	-	30.00K
Citadel advisors	26.95K	-	26.95K

Top Sellers

Holder	Shares	% Assets	Change
Awm investment company	-	-	-650.00K
Timelo investment management	-	-	-361.40K
Aigh capital management	-	-	-300.77K
Hohimer wealth management	-	-	-225.00K
Carlson capital l p	-	-	-140.00K

New Positions

Holder	Shares	% Assets	Change	Value
Envestnet asset management	30.00K	-	30.00K	$49.80K
Citadel advisors	26.95K	-	26.95K	$44.74K
Millennium management	13.62K	-	13.62K	$22.62K
Susquehanna group, llp	10.18K	-	10.18K	$16.90K
Royal bank of canada	338.00	-	338.00	$1.00K

Sold Out

Holder	Change
Jpmorgan chase	-70.00
Fmr	-101.00
Opal wealth advisors	-500.00
Advisor group	-1.17K
Sandy spring bank	-2.00K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	38	-17.39%	4,196,749	-20.97%	10	4.19%	15	-21.05%	4	-42.86%
Jun 30, 2024	46	-	5,310,353	-25.11%	15	3.56%	19	-24.00%	7	-12.50%
Mar 31, 2024	46	27.78%	7,090,800	-0.89%	21	3.70%	25	56.25%	8	300.00%
Dec 31, 2023	36	5.88%	7,154,655	0.15%	23	4.31%	16	128.57%	2	-60.00%
Sep 30, 2023	34	3.03%	7,143,667	1.94%	23	4.20%	7	-50.00%	5	-28.57%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.01M	2.52%	-
Vanguard Institutional Extnd Mkt Idx Tr	200.58K	0.49%	-
Fidelity Extended Market Index	196.57K	0.49%	45.79K
Bridgeway Ultra-Small Company Market	76.70K	0.19%	-
iShares Micro-Cap ETF	71.61K	0.18%	-
BlackRock Extended Equity Market K	64.70K	0.16%	-27.00
Fidelity Series Total Market Index	45.43K	0.11%	21.34K
Fidelity Total Market Index	30.56K	0.08%	-
NT Ext Equity Mkt Idx Fd - NL	26.89K	0.07%	-
NT Ext Equity Mkt Idx Fd - DC - NL - T2	21.66K	0.05%	66.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 14, 2024	Ricciardi Lisa	CEO & President	Buy	$9.97K
Nov 29, 2022	RICHSTONE ELLEN B	-	Buy	$26.55K
Nov 28, 2022	Fletcher Aaron G.L.	-	Buy	$5.23K
Nov 28, 2022	Fletcher Aaron G.L.	-	Buy	$4.96K
Nov 28, 2022	Fletcher Aaron G.L.	-	Buy	$32.38K

Insider Transactions Trends

Date	Buy	Sell
2024 Q2	-	-
2024 Q1	1	-
2023 Q4	-	-
2023 Q2	-	-
2023 Q1	-	-

CGTX Ownership FAQ

Who Owns Cognition Therapeutics?

Cognition Therapeutics shareholders are primarily institutional investors at 10.38%, followed by 0.54% insiders and 89.08% retail investors. The average institutional ownership in Cognition Therapeutics's industry, Biotech Stocks , is 47.04%, which Cognition Therapeutics falls below.

Who owns the most shares of Cognition Therapeutics?

Cognition Therapeutics’s largest shareholders are Vanguard group (1.15M shares, 3.40%), Alyeska investment group (500K shares, 1.48%), and Geode capital management (244.77K shares, 0.73%). Together, they hold 5.61% of Cognition Therapeutics’s total shares outstanding.

Does Blackrock own Cognition Therapeutics?

Yes, BlackRock owns 0.45% of Cognition Therapeutics, totaling 152.58K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 253.28K$. In the last quarter, BlackRock increased its holdings by 96.76K shares, a 173.34% change.

Who is Cognition Therapeutics’s biggest shareholder by percentage of total assets invested?

Cm management is Cognition Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.30% of its assets in 200K Cognition Therapeutics shares, valued at 332K$.

Who is the top mutual fund holder of Cognition Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cognition Therapeutics shares, with 2.52% of its total shares outstanding invested in 1.01M Cognition Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools